5 studies found for:    "Corticobasal degeneration"
Show Display Options
Rank Status Study
1 Completed
Has Results
A Pilot Trial of Lithium in Subjects With Progressive Supranuclear Palsy or Corticobasal Degeneration
Conditions: Progressive Supranuclear Palsy;   Corticobasal Degeneration
Intervention: Drug: Lithium
2 Unknown  Repetitive Transcranial Magnetic Stimulation (TMS) for Progressive Supranuclear Palsy and Corticobasal Degeneration
Conditions: Progressive Supranuclear Palsy;   Corticobasal Degeneration;   Parkinsonism
Intervention:
3 Recruiting 4 Repeat Tauopathy Neuroimaging Initiative
Conditions: Progressive Supranuclear Palsy;   Corticobasal Degeneration
Intervention: Other: Observational Study
4 Active, not recruiting Davunetide (AL-108) in Predicted Tauopathies - Pilot Study
Conditions: Predicted Tauopathies, Including:;   Progressive Supranuclear Palsy;   Frontotemporal Dementia With Parkinsonism Linked to Chromosome 17;   Corticobasal Degeneration Syndrome;   Progressive Nonfluent Aphasia
Interventions: Drug: davunetide (AL-108, NAP);   Drug: Placebo nasal spray
5 Not yet recruiting Clinical Study to Investigate the Efficacy and Safety of Two Dose Levels of NT 201 Versus Placebo in Treating Chronic Troublesome Sialorrhea in Various Neurological Conditions
Conditions: Chronic Troublesome Sialorrhea Resulting From Neurological Conditions in Adults With Parkinson's Disease or Atypical Parkinsonism (Multiple;   System Atrophy, Corticobasal Degeneration or Progressive Supranuclear Palsy), or After Stroke or Traumatic Brain Injury
Interventions: Drug: IncobotulinumtoxinA (100 Units);   Drug: IncobotulinumtoxinA (75 Units);   Drug: Placebo

Indicates status has not been verified in more than two years